CCEL
CryoCell International Inc
NYSE MKT: CCEL · HEALTHCARE · MEDICAL CARE FACILITIES
$3.51
-0.28% today
Updated 2026-04-30
Market cap
$29.56M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.32
Dividend yield
3.84%
52W range
$3 – $6
Volume
0.0M
CryoCell International Inc (CCEL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.18M | $17.46M | $17.28M | $16.33M | $17.64M | $17.92M | $17.97M | $18.99M | $20.13M | $21.09M | $23.13M | $25.38M | $29.22M | $31.82M | $31.15M | $28.88M | $30.34M | $31.34M | $31.99M | $31.57M |
| Revenue growth (YoY) | — | +1.6% | -1.0% | -5.5% | +8.0% | +1.6% | +0.3% | +5.7% | +6.0% | +4.8% | +9.7% | +9.8% | +15.1% | +8.9% | -2.1% | -7.3% | +5.0% | +3.3% | +2.0% | -1.3% |
| Cost of revenue | $6.07M | $6.59M | $6.11M | $4.53M | $4.50M | $4.40M | $4.89M | $5.32M | $5.63M | $5.63M | $5.77M | $6.72M | $8.54M | $10.04M | $9.66M | $8.99M | $8.79M | $8.44M | $7.95M | $7.38M |
| Gross profit | $11.11M | $10.87M | $11.16M | $11.79M | $13.13M | $13.52M | $13.08M | $13.67M | $14.49M | $15.46M | $17.35M | $18.66M | $20.68M | $21.78M | $21.49M | $19.90M | $21.54M | $22.90M | $24.04M | $24.19M |
| Gross margin | 64.7% | 62.2% | 64.6% | 72.2% | 74.5% | 75.4% | 72.8% | 72.0% | 72.0% | 73.3% | 75.0% | 73.5% | 70.8% | 68.5% | 69.0% | 68.9% | 71.0% | 73.1% | 75.2% | 76.6% |
| R&D | $486164.00 | $545489.00 | $194462.00 | $102414.00 | $132991.00 | $184047.00 | $109640.00 | $36168.00 | $64367.00 | $45780.00 | $53097.00 | $41165.00 | $91845.00 | $30145.00 | $23851.00 | $49870.00 | $384789.00 | $1.17M | $1.24M | $376263.00 |
| SG&A | $12.96M | $14.46M | $10.83M | $8.94M | $9.49M | $12.41M | $14.43M | $11.37M | $12.25M | $12.39M | $14.72M | $13.48M | $15.63M | $14.89M | $14.29M | $14.63M | $15.58M | $17.12M | $18.52M | $18.22M |
| Operating income | $-2.96M | $-4.67M | $-326746.00 | $1.67M | $3.22M | $-276742.00 | $-1.71M | $1.70M | $1.98M | $2.93M | $433594.00 | $5.01M | $5.19M | $5.06M | $7.66M | $4.02M | $4.02M | $-12.30M | $3.48M | $482394.00 |
| Operating margin | -17.2% | -26.8% | -1.9% | 10.2% | 18.3% | -1.5% | -9.5% | 9.0% | 9.8% | 13.9% | 1.9% | 19.7% | 17.8% | 15.9% | 24.6% | 13.9% | 13.3% | -39.3% | 10.9% | 1.5% |
| EBITDA | $-2.24M | $-3.93M | $1.38M | $3.63M | $3.65M | $112994.00 | $-1.35M | $1.99M | $2.21M | $2.49M | $-1.25M | $5.16M | $5.48M | $5.50M | $7.22M | $5.32M | $6.65M | $-10.42M | $1.42M | $480577.00 |
| EBITDA margin | -13.0% | -22.5% | 8.0% | 22.3% | 20.7% | 0.6% | -7.5% | 10.5% | 11.0% | 11.8% | -5.4% | 20.3% | 18.8% | 17.3% | 23.2% | 18.4% | 21.9% | -33.2% | 4.4% | 1.5% |
| EBIT | $-2.96M | $-4.67M | $700699.00 | $2.96M | $3.07M | $-466853.00 | $-1.81M | $1.60M | $1.83M | $2.25M | $-1.53M | $4.93M | $5.16M | $5.09M | $6.58M | $3.99M | $4.84M | $-12.13M | $939437.00 | $-270897.00 |
| Interest expense | $1.02M | $1.39M | $1.32M | $1.42M | $1.28M | $1.46M | $1.02M | $1.40M | $1.15M | $1.30M | $947340.00 | $1.30M | $1.55M | $1.70M | $1.54M | $1.38M | $1.52M | $1.24M | $1.86M | $2.07M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-2.81M | $-5.01M | $-760419.00 | $1.42M | $3.41M | $-2.10M | $-6.31M | $27436.00 | $553623.00 | $8.11M | $-1.32M | $2.32M | $-854824.00 | $2.29M | $3.62M | $2.08M | $2.77M | $-9.52M | $402095.00 | $-2.43M |
| Net income growth (YoY) | — | -78.0% | +84.8% | +287.4% | +139.4% | -161.4% | -201.0% | +100.4% | +1917.9% | +1364.2% | -116.3% | +275.3% | -136.9% | +368.0% | +58.2% | -42.5% | +33.0% | -443.6% | +104.2% | -704.2% |
| Profit margin | -16.4% | -28.7% | -4.4% | 8.7% | 19.3% | -11.7% | -35.1% | 0.1% | 2.8% | 38.4% | -5.7% | 9.1% | -2.9% | 7.2% | 11.6% | 7.2% | 9.1% | -30.4% | 1.3% | -7.7% |